Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcia Wang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Computer Sciences|November 25, 2003
Design of diverse and focused combinatorial libraries using an alternating algorithmS Stanley Young, Marcia Wang, Fei Gu
Open Forum Infectious Diseases|September 5, 2024
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE StudyAndrew Clark, Manyu Prakash, Shiven Chabria, et al.
Radiologia Brasileira|April 28, 2020
Focal hyperechoic liver lesions in children: far beyond hemangiomas - pictorial essaySilvia Maria Sucena da Rocha, Maurício Gustavo Ieiri Yamanari, Marcia Wang Matsuoka, et al.
Radiologia Brasileira|May 4, 2016
Ultrasound guided injection of botulinum toxin into the salivary glands of children with neurological disordersMarcia Wang Matsuoka, Sílvia Maria Sucena da Rocha, Lisa Suzuki, et al.
Radiologia Brasileira|December 11, 2020
Use of lung ultrasound in neonates during the COVID-19 pandemicMarcia Wang Matsuoka, Silvia Maria Sucena da Rocha, Maria Augusta Bento Cicaroni Gibelli, et al.
BMC Infectious Diseases|February 24, 2026
SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistanceCarlos Grasa, Nicolas Salvadori, Alessandra Nardone, et al.
The Patient|June 28, 2021
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced IndividualsSarah-Jane Anderson, Miranda Murray, David Cella, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2025
Efficacy and Safety of the Two-Drug Regimen Dolutegravir-Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-Label, Phase 3b TrialThanyawee Puthanakit, Linda Aurpibul, Monica Lopez, et al.
Frontiers in Immunology|June 12, 2024
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE studyJosep M Llibre, Judith A Aberg, Sharon Walmsley, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Computer Sciences|November 25, 2003
Design of diverse and focused combinatorial libraries using an alternating algorithmS Stanley Young, Marcia Wang, Fei Gu
Open Forum Infectious Diseases|September 5, 2024
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE StudyAndrew Clark, Manyu Prakash, Shiven Chabria, et al.
Radiologia Brasileira|April 28, 2020
Focal hyperechoic liver lesions in children: far beyond hemangiomas - pictorial essaySilvia Maria Sucena da Rocha, Maurício Gustavo Ieiri Yamanari, Marcia Wang Matsuoka, et al.
Radiologia Brasileira|May 4, 2016
Ultrasound guided injection of botulinum toxin into the salivary glands of children with neurological disordersMarcia Wang Matsuoka, Sílvia Maria Sucena da Rocha, Lisa Suzuki, et al.
Radiologia Brasileira|December 11, 2020
Use of lung ultrasound in neonates during the COVID-19 pandemicMarcia Wang Matsuoka, Silvia Maria Sucena da Rocha, Maria Augusta Bento Cicaroni Gibelli, et al.
BMC Infectious Diseases|February 24, 2026
SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistanceCarlos Grasa, Nicolas Salvadori, Alessandra Nardone, et al.
The Patient|June 28, 2021
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced IndividualsSarah-Jane Anderson, Miranda Murray, David Cella, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2025
Efficacy and Safety of the Two-Drug Regimen Dolutegravir-Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-Label, Phase 3b TrialThanyawee Puthanakit, Linda Aurpibul, Monica Lopez, et al.
Frontiers in Immunology|June 12, 2024
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE studyJosep M Llibre, Judith A Aberg, Sharon Walmsley, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
Pageof 2